Roxithromycin Reduces Damage from Sulfur Mustard in Lung Cells
Author Information
Author(s): Gao Xiugong, Ray Radharaman, Xiao Yan, Barker Peter E, Ray Prabhati
Primary Institution: Walter Reed Army Institute of Research
Hypothesis
Can roxithromycin inhibit the cytotoxicity and inflammation caused by sulfur mustard in human respiratory epithelial cells?
Conclusion
Roxithromycin effectively reduces the cytotoxicity and inflammation caused by sulfur mustard in human respiratory epithelial cells.
Supporting Evidence
- Roxithromycin decreased sulfur mustard cytotoxicity in both SAE and BTE cells.
- Roxithromycin inhibited the overproduction of proinflammatory cytokines IL-1β, IL-6, IL-8, and TNF.
- The study suggests macrolide antibiotics may serve as potential therapeutics for sulfur mustard exposure.
Takeaway
Roxithromycin, an antibiotic, helps protect lung cells from damage caused by a harmful chemical called sulfur mustard.
Methodology
The study used in vitro models of human small airway epithelial and bronchial/tracheal epithelial cells exposed to sulfur mustard, assessing cell viability and inflammatory cytokine expression.
Limitations
The study was conducted in vitro, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website